Shortages in chemotherapy drugs have forced some cancer centers to stop putting new patients on some therapies. In February, the U.S. government stepped in to allow shipments of cancer-fighting drugs from India and Australia. The drug shortages extend to antibiotics, anesthetics, vaccines and ADHD medications. Demand outstripped the supply of 178 drugs in 2010, according to the Food and Drug Administration. The FDA says 54% of the 2010 shortages were due to manufacturing problems that led to plant shutdowns. Drugmakers acknowledge the quality-control issues, but add that the FDA is understaffed to review existing and new manufacturing facilities. Others blame the shortage problem on the government’s tight price controls on generic drugs slimming down profit margins.
The Illinois carrier recently raised $35 million through a stock offering.
One of the recorded votes on amendments was on a jab at short-term health insurance.
The policy will offer the insureds access to the SilverSneakers and WholeHealth Living Choices programs.
Sponsored by Fidelity Investments
Get insights into the mindset that’s driving today’s advisors to make a move--and help realize their unique business vision.
Don’t miss crucial news and insights you need to make informed investment advisory decisions. Join ThinkAdvisor.com now!
- Free unlimited access to ThinkAdvisor.com which provides advisors, like you, with comprehensive coverage of the products, services and trends necessary to guide your clients in making critical wealth, health and life decisions.
- Exclusive discounts on ALM and ThinkAdvisor events.
- Access to other award-winning ALM websites including TreasuryandRisk.com and Law.com.
Copyright © 2019 ALM Media Properties, LLC. All Rights Reserved.